BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 903666)

  • 1. [3H]Thymidine labeling of dermal endothelial cells in scleroderma.
    Fleischmajer R; Perlish JS
    J Invest Dermatol; 1977 Oct; 69(4):379-82. PubMed ID: 903666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin capillary changes in early systemic scleroderma. Electron microscopy and "in vitro" autoradiography with tritiated thymidine.
    Fleischmajer R; Perlish JS; Shaw KV; Pirozzi DJ
    Arch Dermatol; 1976 Nov; 112(11):1553-7. PubMed ID: 984860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic differentiation between localized and systemic scleroderma.
    Torres JE; Sánchez JL
    Am J Dermatopathol; 1998 Jun; 20(3):242-5. PubMed ID: 9650695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological distinction between progressive and circumscript scleroderma].
    Ishikawa H; Mori S
    Hautarzt; 1972 Sep; 23(9):404-9. PubMed ID: 4264853
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo study of scleroderma by non-invasive techniques.
    Kalis B; De Rigal J; Léonard F; le Lévêque JL; De Riche O; Corre YL; Lacharriere OD
    Br J Dermatol; 1990 Jun; 122(6):785-91. PubMed ID: 2369559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperplasia of dermal microvascular pericytes in scleroderma.
    Helmbold P; Fiedler E; Fischer M; Marsch WCh
    J Cutan Pathol; 2004 Jul; 31(6):431-40. PubMed ID: 15186431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular lesions and fibroblast metabolism in inflammatory diseases].
    Lapière CM
    Phlebologie; 1987; 40(1):21-9. PubMed ID: 3575433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucin deposits in morphea and systemic scleroderma.
    Rongioletti F; Gambini C; Micalizzi C; Pastorino A; Rebora A
    Dermatology; 1994; 189(2):157-8. PubMed ID: 8075444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active proliferation of telangiectases in skin of patients with progressive systemic sclerosis (PSS).
    Kazandjian S; Bruneval P; Fiessinger JN; Camilleri JP; Housset E
    Arch Dermatol Res; 1986; 279(1):8-11. PubMed ID: 3813654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell renewal in skin of patients with progressive systemic sclerosis (PSS): an in vitro autoradiographic study.
    Kazandjian S; Fiessinger JN; Camilleri JP; Dadoune JP; Housset E
    Acta Derm Venereol; 1982; 62(5):425-9. PubMed ID: 6183893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular infiltrates in scleroderma skin.
    Fleischmajer R; Perlish JS; Reeves JR
    Arthritis Rheum; 1977 May; 20(4):975-84. PubMed ID: 861067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma.
    Rodnan GP; Lipinski E; Luksick J
    Arthritis Rheum; 1979 Feb; 22(2):130-40. PubMed ID: 420706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous fibrinolytic activity in scleroderma.
    Lotti T; Cerinic MM; Marmugi D; Fabbri P
    Clin Exp Rheumatol; 1985; 3(3):249-53. PubMed ID: 4053443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of [3H]-thymidine uptake and alpha 1(I) procollagen mRNA expression in systemic sclerosis skin fibroblasts--an in situ hybridization study.
    Ohtsuka T; Koibuchi N; Sakai H; Yamakage A; Yamazaki S
    Arch Dermatol Res; 2000 May; 292(5):248-55. PubMed ID: 10867813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural and biochemical studies of collagen in scleroderma].
    Dabrowski J; Stachów A; Jabłońska S; Iwańska J; Walski M
    Przegl Dermatol; 1977; 64(6):665-71. PubMed ID: 609755
    [No Abstract]   [Full Text] [Related]  

  • 17. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
    Yamamoto T; Nishioka K
    Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies eluted from lymphoid cell membrane. Occurrence in certain varieties of scleroderma.
    Cormane RH; Hamerlinck F; Nunzi E
    Arch Dermatol; 1979 Jun; 115(6):709-12. PubMed ID: 453872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration.
    de-Sá-Earp AP; do Nascimento AP; Carneiro SC; Porto LC; Monte-Alto-Costa A
    Am J Dermatopathol; 2013 Jun; 35(4):438-44. PubMed ID: 23262669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.